Company Overview and News

4
Sensex, Nifty turn choppy on weak Asian cues

2018-07-16 freepressjournal.in
Mumbai: The BSE Sensex turned choppy after rising over 117 points in opening trade, amid weak Asian cues and foreign fund outflows. The broader Nifty, too, slipped below the 11,000-mark. The 30-share index fell 74.69 points, or 0.20 per cent, to 36,466.94 after touching a high of 36,558.71 in opening trade.
YESBANK AXB IBN 532648 YYBKY 533278 532215 AXBKY 500182 AXBA ICICIBANK 500470 TTST TATASTEEL TATLY AXISBANK 532174 HEROMOTOCO HRTQY 500570 TATAMOTORS CLNDY COALINDIA TTM

4
Tata Motors, Mahindra top RD spenders in auto industry

2018-07-15 moneycontrol
Homegrown companies Tata Motors and Mahindra & Mahindra were the biggest spenders on research and development in 2016-17 among 25 automakers in India which together invested Rs 6,344 crore, latest industry data showed.
BAJAJ-AUTO 532977 505200 CMQMY CUMMINSIND HEROMOTOCO 500477 500570 TATAMOTORS EICHERMOT 500033 ASHOKLEY ECQRY FORCEMOT MRZUY AKLD 532500 500182 500480 MARUTI 7269 501455 HRTQY GREAVESCOT AKLS TTM

1
Sensex slips from record on profit-booking

2018-07-13 freepressjournal.in
Mumbai: The BSE Sensex retreated from record high to end flat at 36,541.63 today in volatile trade as investors booked profit in recent gainers despite firm global cues.
BAJAJ-AUTO 500325 RELIANCE 532977 BHRQY 533278 532215 500470 AXISBANK RIGD HDFCBANK HEROMOTOCO BHARTIARTL CLNDY RLNIY YESBANK AXB IBN 532648 YYBKY AXBKY 500182 532454 AXBA ICICIBANK TTST TATASTEEL TATLY HDB 532174 500180 HRTQY COALINDIA

0
Bajaj regains number two spot in motorcycles, unseats Honda

2018-07-13 moneycontrol
A stellar rise in domestic volumes helped Bajaj Auto regain the number two spot in the motorcycle segment unseating Japanese giant Honda which has been steadily improving its hold on the market.
BAJAJ-AUTO 500182 HEROMOTOCO 532977 HRTQY

4
Auto stocks skid on proposed tax on petrol, diesel cars

2018-07-11 livemint
New Delhi: Investors on Wednesday dumped auto stocks following reports that the finance ministry is considering a proposal for higher taxes on petrol and diesel cars to push adoption of electric vehicles in India. The Auto Index of the BSE fell to a six-month low to 24,838.52 even as the benchmark Sensex rose 0.07%, or 26.31 points, to 36,265.93.
ECQRY AKLD 500182 505200 HEROMOTOCO 500477 HRTQY 500570 TATAMOTORS EICHERMOT AKLS ASHOKLEY TTM

0
Hero MotoCorp stretches lead over HMSI in first quarter

2018-07-10 moneycontrol
Two-wheeler market leader Hero MotoCorp has increased its lead over rival Honda Motorcycle and Scooter India (HMSI) in the first quarter of the current fiscal. According to data released by the Society of Indian Automobile Manufacturers (SIAM), Hero MotoCorp sold 20,60,342 bikes and scooters in the April-June period as compared to 16,90,423 units sold by HMSI, a gap of 3,69,919.
BAJAJ-AUTO 500182 HEROMOTOCO 532977 HRTQY

0
US-China trade war tensions to take centre stage in coming week; These 3 stocks to be in focus

2018-07-08 moneycontrol
The upcoming week will be important for the market as developments around imposition of US-China tariffs are likely to stay in focus through the week.
BAJAJ-AUTO KESORAMIND SHALPAINTS 532418 KTKBANK 532218 532977 SOUTHBANK 532187 INOXWIND HEROMOTOCO 500231 502937 INDUSINDBK VTUWY 533269 500182 532652 532210 ONP UMANGDAIR CUB HRTQY 539083 509874 KRIDF WABAG ANDHRABANK

0
Hero MotoCorp Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-07-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500182 HEROMOTOCO HRTQY

4
An evening walk down Dalal Street: Trade war fears fail to impact Sensex, Nifty

2018-07-06 moneycontrol
The S&P BSE Sensex erased most of its intraday gains while the Nifty50 failed to close above its crucial level of 10,800 levels on Friday as investors prefer to book profits at higher levels.
BAJAJ-AUTO 500325 RELIANCE HCTHY 532977 BHRQY TTNQY 533137 DEN 532540 532461 RIGD 532281 HEROMOTOCO 500570 BHARTIARTL TATAMOTORS RLNIY IBN 500182 532454 ICICIBANK PNJZY 532174 HCLTECH TCS PNB HRTQY TTM

4
Sensex recovers 116 points on mixed global cues

2018-07-06 freepressjournal.in
Mumbai: The BSE Sensex turned positive after opening 42 points lower in the early trade today as fresh buying seen on select counters led by oils & gas, realty, auto and IT sectors amid mixed global cues.
BAJAJ-AUTO YESBANK ALNSE AXB 532648 YYBKY 532977 BHRQY 532215 AXBKY 500182 532454 AXBA AXISBANK HEROMOTOCO HRTQY 500570 BHARTIARTL TATAMOTORS TTM

0
Hero MotoCorp Limited - Trading Window

2018-07-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500182 HEROMOTOCO HRTQY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

15h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

17h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 006327327